WHAT IS FoLix?
FoLix is a revolutionary non-ablative fractional laser system using hair stimulation technology, providing effective, safe, and simple treatment for women and men.
FIRST FDA-CLEARED
The first FDA-cleared fractional laser for hair loss treatment with FLX™ technology
PROVEN RESULTS
Clinical studies show increase in hair count and improvement in scalp hair appearance*
NATURAL AND SAFE
Leveraging the body’s own processes for hair stimulation without chemicals
SIMPLE 30 MIN PROCEDURE
Simple to use, easy to learn, quick to treat. Without anesthesia, needles or downtime
FLX™ Laser Technology
Unique algorithm ensure optimal irradiance and area coverage, to maximize operational efficiency, patient comfort, and clinical outcomes.FoliCool™ Tip
(Patent Pending)
Enhances safety and comfort with constant cooling. Designed to separate the hair for smooth treatment.
Intuitive User Interface
Incorporating FDA-cleared settings ensuring efficient, consistent treatments.FLX™ Technology
Ensures optimal irradiance and area coverage by homogenous placement of the laser’s micro-beams onto the tissue. This promises patients’ safety and minimal discomfort while allowing to reach the required settings to achieve results.Customized Settings
Ensuring productivity due to customized settings based on the type of area treated and patient tolerabilityUnlock Nature with Science
FoLix uses targeted laser energy for dermal coagulation, activating natural healing processes. This boosts blood flow, cytokine activity, and hair follicle stimulation.
The Power of Laser
Meet your patients’ preferences with no chemicals, no needles, no anesthesia, no surgery and no after-care.Optimized Treatment Protocol
3-6 sessions every four weeks, plus maintenance 2-3 times a year to sustain and enhance the results.Quick Treatment & Outstanding Results
Offer your patients superior outcomes and satisfaction in a 30-minute treatment with minimal discomfort and no downtime.
TRUST SCIENCE,
TRUST FoLix
Proven results in prospective and retrospective studies, with over 120 participating patients, led by industry experts.
Clinical studies show an increase in hair count, an increase in the number of follicular units per cm2 and noticeable improvement in scalp hair appearance*
Courtesy of LaserMed clinic
Courtesy of LaserMed clinic
Courtesy of LaserMed clinic
Courtesy of LaserMed clinic
Courtesy of LaserMed clinic
Courtesy of LaserMed clinic
Courtesy of LaserMed clinic
Courtesy of LaserMed clinic
HEAR FROM THE EXPERTS
Dr. Marc Avram, Harvard-trained, board-certified dermatologist who specializes in hair loss and hair transplantation in private practice in New York City. Clinical professor of dermatology at Cornell Medical Center.
Dr. Neil Sadick, a leading recognized dermatologist involved in the research of advanced technologies and treatments for hair loss. Clinical Professor of Dermatology at Cornell Medical College, and Adjunct Professor, Department of Dermatology at the University of Minnesota.
Dr. Arruda, board-certified dermatologist and research director with experience in medical device development, cosmetic dermatology, and hair loss treatments.
CONTACT US
The FoLix release is per regional regulatory approval in the relevant jurisdiction. The approved jurisdictions is United States
Indication for use: Improving the appearance of scalp hair in adult males and females with Fitzpatrick skin types I to IV, who are seeking treatment for hair loss.
Warnings and risks: FoLix treatment could cause redness, swelling, scarring, and pigmentation change. The use of FoLix is contraindicated for patients with any concurrent cancer or history of skin cancer, active infection, fungal or bacterial diseases. See the machine user manual for a complete list of contraindications and risks.
*Measured in 1-month and 3-months follow ups following last treatment session, compared to baseline. Data on file.
Testimonial represents a specific experience of a paid spokesperson. Experience of others may vary.
PB-00076340 Rev A